AstraZeneca to Invest $90-Mn in India over Next 5 Years

Biopharmaceutical firm AstraZeneca has revealed plans to invest $90-mn (around Rs. 590-crore) in India over the next five years. The announcement followed the signing of a bilateral innovation partnership for a sustainable future between Sweden and India.

“Our latest investment reflects our commitment to address the unmet needs in non-communicable diseases, enable high-value job creation and boost medical innovation in the country,” AstraZeneca Executive VP for International Region Mr. Leon Wang said.

AstraZeneca said the investment will be targeted at strengthening manufacturing, clinical operations, patient safety & regulatory science, IT services and commercial operations.

The company believes, this investment commitment across AstraZeneca’s business footprint in India will make a positive impact. It also aligns closely with the government’s vision for healthcare and innovation, Mr. Wang said.